S6E4: 4. ”The journey to a new drug”: understanding molecules and receptors

This podcast, the fourth in our drug development series “the journey to a new drug,” brings you my conversation with Dr. Stephen Betz, cofounder at Crinetics Pharmaceutical. Our discussion spotlights new drugs for acromegaly, Cushing’s, and pediatric hyperinsulinism, currently under development at Crinetics. It includes a fascinating talk on molecules and how they work with cell receptors to eventually provide a launching pad for new drugs.

We hope this podcast will serve up a better understanding of the many steps required to find and bring new medications and therapies to patients.